S5.

Genotype and allele frequencies of VEGI gene polymorphisms and TNBC status

SNP ID	Genotype	TNBC No. (%)	Non-TNBC No. (%)	OR (95% CI)	P value
VEGI, vascular endothelial growth inhibitor; TNBC, triple negative breast cancer.
rs6478106	CC	42 (43.30)	227 (44.86)	Reference
	CT	51 (52.58)	235 (46.44)	1.173 (0.750-1.835)	0.484
	TT	4 (4.12)	44 (8.70)	0.491 (0.168-1.440)	0.265
	Dominant			1.065 (0.687-1.651)	0.777
	Recessive			0.452 (0.158-1.287)	0.153
	Allelic			0.932 (0.668-1.301)	0.680
rs4263839	GG	22 (21.57)	147 (28.65)	Reference
	GA	60 (58.82)	276 (53.80)	1.453 (0.857-2.463)	0.164
	AA	20 (19.61)	90 (17.54)	1.485 (0.768-2.873)	0.238
	Dominant			1.461 (0.878-2.430)	0.143
	Recessive			1.146 (0.669-1.965)	0.619
	Allelic			1.202 (0.890-1.624)	0.230
rs4979462	CC	49 (50.52)	276 (54.33)	Reference
	CT	43 (44.33)	196 (38.58)	1.236 (0.789-1.935)	0.355
	TT	5 (5.15)	36 (7.09)	0.782 (0.293-2.092)	0.624
	Dominant			1.165 (0.755-1.800)	0.490
	Recessive			0.713 (0.272-1.864)	0.488
	Allelic			1.049 (0.743-1.482)	0.785
rs7848647	TT	28 (28.28)	117 (23.12)	Reference
	TC	52 (52.53)	279 (55.14)	0.779 (0.469-1.299)	0.334
	CC	19 (19.19)	110 (21.74)	0.722 (0.381-1.366)	0.315
	Dominant			0.763 (0.470-1.237)	0.271
	Recessive			0.855 (0.497-1.472)	0.571
	Allelic			0.857 (0.631-1.163)	0.321